Exelon and Modafinil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 5 people who take Exelon and Modafinil. Common interactions include abasia among females, and death among males.
The phase IV clinical study analyzes what interactions people who take Exelon and Modafinil have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
5 people who take Exelon and Modafinil together, and have interactions are studied.
What is Exelon?
Exelon has active ingredients of rivastigmine tartrate. It is used in alzheimer's disease. Currently, eHealthMe is studying from 11,059 Exelon users.
What is Modafinil?
Modafinil has active ingredients of modafinil. It is used in narcolepsy. Currently, eHealthMe is studying from 19,400 Modafinil users.
Number of Exelon and Modafinil reports submitted per year:
Common Exelon and Modafinil drug interactions by gender *:
female:
- Abasia
male:
- Death
- Dizziness
- Rash vesicular
- Fall
- Hypotension
- Inflammation
- Lower limb fracture
- Polyuria
- Scratch
- Food allergy
Common Exelon and Modafinil drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Death
- Dizziness
- Rash
- Rash vesicular
- Fall
- Hypotension
- Inflammation
- Lower limb fracture
- Polyuria
- Scratch
* Approximation only. Some reports may have incomplete information.
Do you take Exelon and Modafinil?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Related studies
Drug side effects by duration, gender and age:
- Exelon side effects (11,059 reports)
- Modafinil side effects (19,400 reports)
Common Exelon drug interactions:
- Exelon and Namenda: 718 reports
- Exelon and Aspirin: 667 reports
- Exelon and Seroquel: 457 reports
- Exelon and Lasix: 323 reports
- Exelon and Lipitor: 319 reports
- Exelon and Plavix: 302 reports
- Exelon and Simvastatin: 292 reports
- Exelon and Risperdal: 277 reports
- Exelon and Metformin: 266 reports
- Exelon and Sinemet: 257 reports
Browse interactions between Exelon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Modafinil drug interactions:
- Modafinil and Xyrem: 8,073 reports
- Modafinil and Vitamin d: 3,338 reports
- Modafinil and Gabapentin: 3,183 reports
- Modafinil and Baclofen: 2,462 reports
- Modafinil and Adderall: 2,274 reports
- Modafinil and Omeprazole: 2,056 reports
- Modafinil and Vitamin d3: 1,907 reports
- Modafinil and Ibu: 1,906 reports
- Modafinil and Profen: 1,890 reports
- Modafinil and Lisinopril: 1,704 reports
Browse interactions between Modafinil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rivastigmine tartrate and modafinil (the active ingredients of Exelon and Modafinil, respectively), and Exelon and Modafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Exelon and Modafinil.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dobutamine Hydrochloride and Upper Respiratory Tract Infection - now
- Spironolactone and Methotrexate drug interaction - 2 seconds ago
- Fosamax and Parathyroid Tumor Benign - 4 seconds ago
- Tramadol and Atacand drug interaction - 9 seconds ago
- Spiriva and Defaecation Urgency - 35 seconds ago
- Sudafed 12 Hour and Rinvoq drug interaction - 41 seconds ago
- Victoza and Saccharomyces drug interaction - 43 seconds ago
- Saxenda and Xeljanz Xr drug interaction - 43 seconds ago
- Pentasa and Vitamin B12 Deficiency - 56 seconds ago
- Decadron and Diabetic Ketoacidosis - 57 seconds ago